PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
Novus Biologicals

Press Release


Receive press releases from Novus Biologicals: By Email RSS Feeds:

New EpiPlus - Histone Modification Antibodies Announced Today


Littleton, CO, October 12, 2011 --(PR.com)-- Novus Biologicals announced today the release of a new group of Epi-PlusTM antibodies for histone modification testing. Over the past several months, Novus has collaborated with 21st Century Biochemicals, a leading manufacturer of custom antibodies and peptides, to generate the most well validated antibodies for modified histones and other epigenetic targets.

Histone modifications are part of a complicated system of checks and balances at the epigenetic level and several histone modifications have been definitively shown to affect the regulation of transcription in a variety of cellular processes.

The laboratory teams at both Novus and 21st Century Biochemicals have performed extensive validation work in multiple assay types, including chromatin immunoprecipitation (ChIP), Western Blot, dot blots using modified peptide arrays, and immunocytochemistry (ICC). Therefore, you can be assured that all Epi-PlusTM antibodies have been extensively characterized and validated, and are of the highest quality compared to other similarly commercially available products.

The complete list of currently available Epi-PlusTM antibodies is available on their site, with the newly added antibodies:

Histone H3.2 K9me2 pT6 (NB21-1053)
Histone H3.2 pS10 (NB21-1091)
Histone H3.2 K4me1(NB21-1021)
Histone H3.2 K9ac (NB21-1074)
Histone H3.2 R2me1 (NB21-1001)
Histone H4 R3me1 (NB21-2011)
Histone H3.2 R8me2s (NB21-1063)

Over the next few months Novus will be releasing additional antibodies for this product line:

699CGP-Histone H3.2 K18me3
708CGP-Histone H3.2 K36ac
710CGP-Histone H3.2 R2me2a
738CGP-Histone H3.2 K18me1

Novus also offers a Histone Modification Map poster for quick and easy reference of the important epigenetic modification sites.

About Novus Biologicals (www.novusbio.com)
Novus Biologicals is a biotechnology company whose mission is to accelerate scientific discovery by developing and marketing unique products in the forefront of science. Novus Biologicals provides primary antibodies, secondary antibodies, conjugated antibodies, proteins, peptides, isotype and loading controls, RNAi, lysates, stem cell lines and antibody labeling kits to the bioscience community. All of Novus' products are 100% guaranteed to work in the species and applications listed on the datasheet. By serving niche and emerging markets, Novus Biologicals has formed and will continue to form ongoing partnerships with leading researchers.

About 21st Century Biochemicals (www.21stcenturybio.com)
21st Century Biochemicals provides solutions for biomedical researchers worldwide ranging from the manufacture of polyclonal and monoclonal antibodies to custom and bioactive peptides, arrays, libraries and peptidomimetics. Consisting of a core of PhD scientists with decades of experience, 21st Century Biochemicals provides peptide and antibody solutions with the most rigorous peptide QC in the industry: nanospray MS and HPLC analysis as well as CID MS/MS peptide sequence confirmation. 100% of the peptides and antibodies provided by 21st Century Biochemicals are manufactured in their facility outside of Boston, MA, providing unmatched product quality and consistency.

###
Contact Information
Novus Biologicals
Amy Chamberlain-Torres
303-730-1950
Contact
www.NovusBio.com

Click here to view the list of recent Press Releases from Novus Biologicals
Promote Your Business